News
The Marató 3Cat finances three IDIBELL projects in sexual and reproductive health
Drs. Laia Alemany, Mireia Martín Satué, Jordi Guiu and Gabriel Capellá will carry out their research projects in sexual and reproductive health thanks to the funds raised by La Marató 2023.
Researchers identify inflammatory markers related to the prognosis of breast cancer
A study by IDIBELL, ICO and IARC has linked the levels of certain inflammatory molecules with mortality in breast cancer patients.
The study, published in the British Journal of Cancer, included 1538 women from eight countries belonging to the EPIC cohort and diagnosed with breast cancer.
Admit therapeutics receives accreditation from college of american pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to ADmit Therapeutics, Barcelona, Spain based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved […]
Aurora Pujol receives funding from the CaixaResearch call for Health Research 2024
The project aims to find a cure for a lethal degenerative genetic disease that affects children, adrenoleukodystrophy.
Researchers identify a potential biomarker of Parkinson’s disease progression
Researchers from IDIBELL and the UB show that the levels of a certain neuronal receptor are increased only in patients with a slow progression of this pathology.
The 9th edition of IDIBELL’s PhD Day is held, this year focused on artificial intelligence
200 researchers and teaching staff have attended the ninth edition of the PhD Day, organized annually by the Committee of Predoctoral Researchers in collaboration with other IDIBELL units. This year’s conference focused on the use of artificial intelligence in research, with a workshop and a round table on the subject.
The Niemann-Pick Foundation donates nearly 105,000 euros to continue with the clinical trial of a drug to stop the disease-related cognitive deterioration
Dr. Gascón thanked the tireless effort of the Niemann-Pick Foundation to
promote research as a tool to improve patients' quality of life.
Efavirenz is an antiretroviral drug used in HIV treatment that improves the
function of an enzyme that regulates cholesterol.
A new study carried out in Bellvitge warns about the bone mass loss after bariatric surgery
A new study by IDIBELL and Bellvitge University Hospital, published in the journal Bone, reveals that some bariatric surgeries can have an impact on bone health, especially in the hip area.
BioCluster, gamification and innovation in health: IDIBELL’s participation in the Smart City Expo World Congress 2024
The Innovation and Health Biocluster presents itself as a key alliance to position L’Hospitalet in research and advanced medicine.